Anti-CD40 antibodies and uses thereof
The present invention relates to anti-CD40 antibodies or antigen-binding fragments thereof that specifically recognize human, cynomolgus monkey and mouse CD40 molecules and weakly agonize said CD40 molecules, as well as immunoconjugates, pharmaceutical compositions and combinations comprising said a...
Saved in:
Main Authors | , , , , |
---|---|
Format | Patent |
Language | Chinese English |
Published |
29.11.2022
|
Subjects | |
Online Access | Get full text |
Cover
Summary: | The present invention relates to anti-CD40 antibodies or antigen-binding fragments thereof that specifically recognize human, cynomolgus monkey and mouse CD40 molecules and weakly agonize said CD40 molecules, as well as immunoconjugates, pharmaceutical compositions and combinations comprising said anti-CD40 antibodies or antigen-binding fragments thereof. The invention also relates to a nucleic acid encoding the anti-CD40 antibody or the antigen binding fragment thereof, a host cell comprising the nucleic acid, and a method for preparing the anti-CD40 antibody or the antigen binding fragment thereof. The invention also relates to the use of the anti-CD40 antibody or the antigen-binding fragment thereof in the prevention or treatment of tumors or infectious diseases in a subject.
本发明涉及特异性识别人、食蟹猴和小鼠CD40分子且弱激动所述CD40分子的抗CD40抗体或其抗原结合片段,以及包含所述抗CD40抗体或其抗原结合片段的免疫缀合物、药物组合物和组合产品。本发明还涉及编码所述抗CD40抗体或其抗原结合片段的核酸及包含所述核酸的宿主细胞,以及制备所述抗CD40抗体或其抗原结合片段的方法。本发明还涉及所述抗CD40抗体或其抗原结合片段在受试者中预防或治疗肿瘤或感染性疾病的用途。 |
---|---|
Bibliography: | Application Number: CN202110577432 |